Tivic Health Reports Second Quarter 2023 Financial Results on August 14th Via Conference Call and Webcast
07 Agosto 2023 - 6:20PM
Business Wire
Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a
health tech company that develops and commercializes bioelectronic
medicine, today announced that it will report financial results for
the first quarter of 2023 via pre-recorded conference call and
webcast on Monday, August 14th, 2023 at 1:30 pm PT / 4:30 pm
ET.
Teleconference Details: Toll-Free: 877-545-0523
International: 973-528-0016 Participant Access Code: 679005
Webcast Link
https://www.webcaster4.com/Webcast/Page/2865/48652
Shareholders also may submit questions in advance of the
earnings call by sending them to the following email address -
ir@tivichealth.com. The deadline for submitting questions in
advance of the webcast/conference call is 5:00 PM ET on August 8th,
2023. Due to time constraints and the nature of the questions
please be advised that not all questions submitted can be
answered.
About Tivic Tivic is a commercial health tech company
advancing the field of bioelectronic medicine. Tivic’s patented
technology platform leverages stimulation on the trigeminal,
sympathetic, and vagus nerve structures. Tivic’s non-invasive and
targeted approach to the treatment of inflammatory chronic health
conditions gives consumers and providers drug-free therapeutic
solutions with high safety profiles, low risk, and broad
applications. Tivic’s first commercial product ClearUP is an FDA
approved, award-winning, handheld bioelectronic sinus device.
ClearUP is clinically proven, doctor-recommended, and is available
through online retailers and commercial distributors. For more
information visit http://tivichealth.com @TivicHealth
Forward-Looking Statements This press release may contain
“forward-looking statements” that are subject to substantial risks
and uncertainties. All statements, other than statements of
historical fact, contained in this press release are
forward-looking statements. Forward-looking statements contained in
this press release may be identified by the use of words such as
“anticipate,” “believe,” “contemplate,” “could,” “estimate,”
“expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,”
“predict,” “project,” “target,” “aim,” “should,” “will” “would,” or
the negative of these words or other similar expressions, although
not all forward-looking statements contain these words.
Forward-looking statements are based on Tivic Health Systems,
Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: market and other conditions; supply
chain constraints; macroeconomic factors, including inflation; the
risks that the ongoing COVID-19 pandemic may disrupt Tivic’s
business more severely than anticipated; and unexpected costs,
charges or expenses that reduce Tivic’s capital resources. Given
these risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. For a discussion of
other risks and uncertainties, and other important factors, any of
which could cause Tivic’s actual results to differ from those
contained in the forward-looking statements, see Tivic’s filings
with the SEC, including, its Annual Report on Form 10-K for the
year ended December 31, 2022, filed with the SEC on March 31, 2023,
under the heading “Risk Factors”; as well as the company’s
subsequent filings with the SEC. Forward-looking statements
contained in this press release are made as of this date, and Tivic
Health Systems, Inc. undertakes no duty to update such information
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230807366624/en/
Media Contact: Kayleigh Westerfield
Kayleigh.Westerfield@tivichealth.com
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025